Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT04146155
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Registry
-
NCT04146155
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04146155. Randomized; single masking; primary purpose treatment. Start 2020-05-01 (actual); primary completion 2021-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease
- Condition
- Type 2 Diabetes
- Condition
- Peripheral Vascular Disorder Due to Diabetes Mellitus
- Intervention (Drug)
- Liraglutide+standard-of-care treatment
- Intervention (Other)
- standard-of-care treatment
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Record details
- Record id
cardio:ct-nct04146155- Content hash
4d522b83fcc72063bab2f95da05edab548f24070a0153f55baa009e73ea4b421